1. Effect of switching from acenocoumarol to phenprocoumon on time in therapeutic range and INR variability: A cohort study

   van Miert, J. H. A., Veeger, N. J. G. M., Ten Cate-Hoek, A. J., Piersma-Wichers, M. & Meijer, K., 10-Jul-2020, In : PLoS ONE. 15, 7, 17 p., e0235639.

   Research output: Contribution to journal › Article › Academic › peer-review

2. Quality of life after switching from well-controlled vitamin K antagonist to direct oral anticoagulant: Little to GAInN

   van Miert, J. H. A., Kooistra, H. A. M., Veeger, N. J. G. M., Westerterp, A., Piersma-Wichers, M. & Meijer, K., Jun-2020, In : Thrombosis Research. 190, p. 69-75 7 p.

   Research output: Contribution to journal › Article › Academic › peer-review

3. Directe orale antistollingsmiddelen ook in Nederland een goede keus

   van Miert, J., Piersma-Wichers, M. & Meijer, K., 19-Jul-2019, In : Huisarts en Wetenschap. 1 p.

   Research output: Contribution to journal › Article › Professional

4. Choosing between continuing vitamin K antagonists (VKA) or switching to a direct oral anticoagulant in currently well-controlled patients on VKA for atrial fibrillation: a randomised controlled trial (GAInN)

   van Miert, J. H. A., Kooistra, H. A. M., Veeger, N. J. G. M., Westerterp, A., Piersma-Wichers, M. & Meijer, K., Aug-2019, In : British Journal of Haematology. 186, 3, p. e21-e23 3 p.

   Research output: Contribution to journal › Article › Academic › peer-review

5. Impact of Vitamin K Antagonists on Quality of Life in a Prospective Cohort of 807 Atrial Fibrillation Patients

   Kooistra, H. A. M., Piersma-Wichers, M., Kluin-Nelemans, H. C., Veeger, N. J. G. M. & Meijer, K., Jul-2016, In : Circulation: Cardiovascular Quality and Outcomes. 9, 4, p. 388-394 7 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (8) »